Shanghai Qian Yu Biotechnology Co., Ltd.

Model Number: QQM67-#0729 Brand Name: QQM Key Specifications/Special Features: Edoxaban (DU-176b, trade names Savaysa, Lixiana) is an oral anticoagulant drug which acts as direct factor Xa inhibitorIt was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery[1] It was also approved by FDA in January 2015 for the prevention of stroke and non–central-nervous-system systemic embolism4-CEC,4CLPVP,BK-EBDP,APPP,MDPHP,5FADB,ADB-F,5F-MN24,FUB-AMB,MMB-FUBINACA,2-NMC,MDPT,4-CDC,4-EMC,4CL-PET,MD-PHP,THPVP,MMBC,Dibutylone,5FSDB005,4CL-PMT,4F-MPH,4MPD,FMXP,BMDP,4CPRC,HEX-EN4FPHPMDMB2201, 5FMDMB2201,Furanylfentanyl,GEFITINIB,IBRUTINIB, ERLOTINIB2-A1MPU-47700, U49900, Mexedrone, Etizolam, 3FPM, Isopropylphenidate, 4FIBF